ASCO Guidelines vs HemeOncBuddy
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
ASCO Guidelines
Access comprehensive cancer care guidelines and interactive tools to inform treatment decisions. This app supports healthcare providers, patients, and caregivers in implementing recommended cancer care options for various cancer types, aiming to improve the quality of care.
- Guideline recommendations for cancer care
- Interactive treatment decision tools
- Supports healthcare providers
- Informs patients and caregivers
- Covers various cancer types
- Regularly updated content
Read full descriptionHide full description
The ASCO Guidelines app is your go-to tool for implementing guideline recommendations into practice. This user-friendly app provides health care providers, patients, and caregivers with the recommended cancer care options for a variety of cancer types. It also includes interactive tools to inform treatment decisions at the point of care, thus increasing the quality of care provided to patients. The ASCO app is free to members and nonmembers, kept up to date, and will continue to grow as more guidelines and tools are added.
HemeOncBuddy
This app provides quick access to practice-changing clinical trials in Hematology and Oncology. It offers simplified summaries of trial background, inclusion/exclusion criteria, primary endpoints, and outcomes for easy reference.
- Practice-changing clinical trial summaries
- Hematology and Oncology focus
- Simplified trial information
- Inclusion and exclusion criteria
- Primary endpoints and outcomes
- Quick reference tool
Read full descriptionHide full description
HemeOncBuddy is a free study hub built for hematology and oncology fellows and trainees - everything you need to keep up with the literature and prep for boards, in one fast, searchable app. WHAT'S INSIDE - 1,500+ pivotal clinical-trial summaries, each in the same structure (background, inclusion criteria, arms, primary/secondary endpoints, median follow-up, key results, notable toxicities) so you can scan them quickly. - A Question Bank with board-style questions, tutor and timed modes, explanations, and progress tracking. - ~2,000 active-recall flashcards across oncology, malignant and benign heme, and pharmacology — plus visual staging decks. - 120+ concise disease-site board-prep notes. - A conference & abstract-deadline tracker so you never miss a submission window. MADE FOR STUDYING - Full dark mode and adjustable text size. - Optional free account (Sign in with Apple, Google, or email) to sync your saved trials, Qbank progress, and notes across iPhone, iPad, and Mac. - No ads. No paywall. No login required to browse. HemeOncBuddy is an educational study aid only. It is not a substitute for medical advice, clinical judgment, or current guidelines, and must not be used to diagnose or treat patients. Always verify against primary literature and current guidelines.
Screenshots
Verdict
The clearest difference is review sentiment: HemeOncBuddy at 100% against ASCO Guidelines's 57%. HemeOncBuddy also leads on rating (5.0 vs 4.8). ASCO Guidelines's advantage is update cadence (every 5 months vs every 24 months) and ratings volume (259 vs 18). On price, ads, in-app purchases and monetization model there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
HemeOncBuddy holds the better App Store score, 5.0 against 4.8. That said, the two scores are not equally well evidenced: ASCO Guidelines has 259 ratings behind it against 18, so its average is the more settled of the two. Written reviews point the same way: 57% of ASCO Guidelines's written reviews are positive against 100% of HemeOncBuddy's.
ASCO Guidelines ships an update every 5 months, HemeOncBuddy every 24 months. Both last shipped on October 24, 2026.
| Parameter | ASCO Guidelines | HemeOncBuddy |
|---|---|---|
| Price | Free | Free |
| Rating | 4.8 (259 ratings) | 5.0 (18 ratings) — better |
| Positive reviews | 57.1% of reviews | 100.0% of reviews — better |
| Number of ratings | 259 — better | 18 |
| Update frequency | Every 5 months — better | Every 24 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 10.0 — better | 15.0 |
| Further details — not scored | ||
| Size | 411 MB | 16 MB |
| Age rating | 12+ | 17+ |
| Developer | American Society of Clinical Oncology | Veli Bakalov |
Customer experience
ASCO Guidelines
HemeOncBuddy
In-app purchases
ASCO Guidelines
No in-app purchases
HemeOncBuddy
No in-app purchases
Questions
Is ASCO Guidelines free?
Is HemeOncBuddy free?
Which has better reviews, ASCO Guidelines or HemeOncBuddy?
Do ASCO Guidelines or HemeOncBuddy have ads?
Which is updated more often, ASCO Guidelines or HemeOncBuddy?
Other comparisons















